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Adipocytes store triglyceride during periods of nutri-
tional affluence and release free fatty acids during
fasting through coordinated cycles of lipogenesis
and lipolysis. While much is known about the acute
regulation of these processes during fasting and
feeding, less is understood about the transcriptional
basis by which adipocytes control lipid handling.
Here, we show that interferon regulatory factor 4
(IRF4) is a critical determinant of the transcriptional
response to nutrient availability in adipocytes. Fast-
ing induces IRF4 in an insulin- and FoxO1-dependent
manner. IRF4 is required for lipolysis, at least in
part due to direct effects on the expression of
adipocyte triglyceride lipase and hormone-sensitive
lipase. Conversely, reduction of IRF4 enhances
lipid synthesis. Mice lacking adipocyte IRF4 exhibit
increased adiposity and deficient lipolysis. These
studies establish a link between IRF4 and the dispo-
sition of calories in adipose tissue, with conse-
quences for systemic metabolic homeostasis.
INTRODUCTION
The current epidemic of obesity has prompted intense investiga-
tion into the molecular mechanisms underlying fat storage and
utilization (Bluher, 2009; Jensen, 2008). Adipose tissue is the
dominant site for storage of excess energy derived from food
intake. Factors that control the synthesis of fat (lipogenesis)
and fat mobilization (lipolysis) are important regulators of triacyl-
glycerol (TAG) accumulation in adipose tissue (Bouchard et al.,
1993; Lafontan, 2008). In the fed state, fatty acids (FAs) are
synthesized in adipocytes through de novo lipogenesis from
nonlipid substrates, and subsequently esterified into TAG.
Conversely, in the fasted state, TAG are broken down into free
fatty acids (FFAs) and glycerol, which are released to supply
the energy needs of other tissues. FFAs and glycerol are sub-
strates for ketogenesis and gluconeogenesis, respectively, inCethe liver, and FFAs is used by skeletal muscle and heart as an
energy source (Duncan et al., 2007).
During cycles of fasting and feeding, adipose tissue lipid
metabolism is controlled by nutrients (such as carbohydrates
and polyunsaturated fatty acids) and by hormones (such as
insulin and catecholamines); the normal interplay of these factors
is essential to maintain normal adipose homeostasis. During
feeding, insulin exerts its prolipogenic functions via a transcrip-
tion factor called sterol regulatory element binding protein 1c
(SREBP1c), while the effects of carbohydrates and polyunsatu-
rated fatty acids are mediated by carbohydrate response
element binding protein (ChREBP) and liver X receptor (LXR),
respectively (Darimont et al., 2006; Eberle et al., 2004; Kersten,
2001; Kim et al., 1998; Uyeda et al., 2002). In contrast, the tran-
scriptional regulation of lipolysis is less well defined.
The recent realization that obesity represents a state of chronic
inflammation has led to the identification of many genes and
proteins, previously thought to act specifically on immune func-
tion, as key regulators of metabolism (Hotamisligil and Erbay,
2008). We previously identified interferon regulatory factors
(IRFs) during an unbiased search for novel transcriptional regula-
tors of adipogenesis based on DNase hypersensitivity (Eguchi
et al., 2008). IRFs are a family of transcription factors involved
in a wide range of immune functions, including lymphopoiesis,
macrophage differentiation, and the regulation of innate immu-
nity, particularly as effectors of toll-like receptor (TLR) signaling
(Honda and Taniguchi, 2006; Tamura et al., 2008). All nine
mammalian IRFs are expressed in adipose tissue in a develop-
mentally regulatedmanner, and IRF1, IRF3, and IRF4 exhibit anti-
adipogenic properties in cultured adipocytes (Eguchi et al.,
2008).Our previous study showed that unlike other IRFmembers,
IRF4 expression is highly restricted to immune cells and adipose
tissue and is more abundant in mature adipocytes than other cell
types in adipose tissue.Additionally, IRF4expression risesduring
differentiation, further suggesting a role in the mature adipocyte
(Eguchi et al., 2008). IRF4 has been studied in the context of
immune regulation and has been shown to be involved in
lymphoid, myeloid, and dendritic cell development (Busslinger,
2004; Lohoff et al., 2002; Tailor et al., 2006). There are no data
describing a role for IRF4 in cellular or organismal metabolism.
To elucidate the functional role of IRF4 in adipocytes, we
studied IRF4-deficient cells and mice lacking IRF4 specificallyll Metabolism 13, 249–259, March 2, 2011 ª2011 Elsevier Inc. 249
Figure 1. IRF4 Expression Is Regulated
during Fasting and Feeding by Insulin and
FoxO1
(A) Nutritional regulation of Irf4 mRNA expression
in murine white adipose tissue (WAT). Male FVB
mice were sacrificed in the fed state, after
a 24 hr fast, or 24 hr after refeeding (n = 7–8).
Data are normalized to 36B4 expression and are
expressed as the fold induction relative to Irf4
mRNA in the fed state. Results are expressed as
mean ± standard deviation (SD).
(B) Nutritional regulation of IRF4 protein expres-
sion in murine WAT, brown adipose tissue (BAT),
and spleen.
(C) IRF4 mRNA expression in human WAT,
sampled pre- and postfasting (n = 7). *p < 0.05
versus prefasting.
(D) Regulation of Irf4 mRNA expression by insulin
in 3T3-L1 adipocytes. 3T3-L1 adipocytes were
incubated in serum-free DMEM with insulin at the
indicated doses for 8 hr (n = 3). Data are normal-
ized to 36B4 and presented as expression relative
to 0 nM insulin. *p < 0.05 versus 0 nM insulin.
Results are expressed as mean ± SD.
(E) Irf4mRNA expression in WAT of streptozotocin
(STZ)-treated mice. Irf4 mRNA expression was
measured by Q-PCR in WAT of 10-week-old
male mice given vehicle (control), STZ, or STZ fol-
lowed by insulin replacement for 24 hr (STZ + Ins)
(n = 8–10/group). Data are normalized to 36B4
and presented as expression relative to control,
*p < 0.05. Results are expressed as mean ± SD.
(F) Irf4 mRNA expression in WAT of fat insulin
receptor knockout (FIRKO) mice (n = 4/group).
Data are normalized to 36B4 and presented as
expression relative to control. Results are ex-
pressed as mean ± SD. *p < 0.05 versus control.
(G) Irf4 mRNA expression in 3T3-L1DCAR adipo-
cytes transduced with adenovirus expressing
EGFP, wild-type (WT), constitutively active (CA), or dominant-negative (DN) FoxO1. Data are normalized to 36B4 and presented as fold induction relative to
EGFP cells. *p < 0.05 versus EGFP cells. Results are expressed as mean ± SD.
(H) Luciferase activity of Irf4 promoter constructs in 3T3-L1 adipocytes. Five days after adipogenic stimulation, 3T3-L1 cells were transfected with the indicated
Irf4 promoter construct. Luciferase activity was measured 24 hr after transfection in the presence (filled bar) or absence (open bar) of insulin. Results are
expressed as mean ± SD (n = 3). *p < 0.05 relative to the same construct without insulin. Results are expressed as mean ± SD.
(I) ChIP assay of FoxO1 binding to Irf4 promoter constructs in 3T3-L1 adipocytes in the presence (filled bar) or absence (open bar) of insulin (n = 3). All results are
normalized to IgG without insulin and are expressed as mean ± SD.
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IRF4 Regulates Adipose Lipid Handlingin adipocytes. Here, we show that IRF4 expression is nutritionally
regulated, an effect mediated by the actions of insulin on FoxO1.
Furthermore, we demonstrate that IRF4 plays a significant role in
the transcriptional regulation of lipid handling in adipocytes, with
consequences for nutrient partitioning and overall adiposity.
RESULTS
IRF4 Gene Expression Is Nutritionally Regulated
in Adipocytes
To investigate a role for IRF4 in mature adipocytes, we began
by asking whether IRF4 is nutritionally regulated. Twenty-four
hours of fasting resulted in dramatic induction of IRF4 at both
the messenger RNA (mRNA) (Figure 1A) and protein (Figure 1B)
level in white adipose tissue (WAT) and brown adipose tissue
(BAT), with subsequent downregulation after refeeding. This
effect is not seen in spleen, one of the few tissues other than250 Cell Metabolism 13, 249–259, March 2, 2011 ª2011 Elsevier Inc.fat that expresses significant levels of IRF4. The time course
for this effect is relatively swift, with significant upregulation of
Irf4 mRNA within 6 hr of food withdrawal, and repression within
an hour of refeeding (Figure S1A available online). We noted
similar regulation of IRF4 in subcutaneous and epididymal
WAT depots (Figure S1B). We next sought to determine
whether this was a rodent-specific effect or whether it could
be relevant to humans. Biopsy samples were obtained from
the subcutaneous fat of male volunteers before and after
72 hr of fasting (see Table S1 for clinical characteristics).
Indeed, IRF4 mRNA rose significantly with fasting in five of
seven patients (Figure 1C; p < 0.05). The effect of fasting and
feeding on IRF4 gene expression in adipose tissue thus appears
to be a conserved response with relevance to human biology,
although because these samples were not fractionated, we
cannot be certain that the effect is contained within the mature
adipocyte per se.
Figure 2. IRF4 Promotes Lipolysis In Vitro via Effects on Lipase Expression
(A) Basal and isoproterenol-stimulated glycerol release (6 hr stimulation) in WT and KOMEFs, with and without the addition of exogenous IRF4. *p < 0.05 (n = 6),
Results are expressed as mean ± SD.
(B) Pnpla2, Lipe, and Plin1 mRNA expression in WT and KO MEFs. *p < 0.05 relative to WT control (n = 3). Results are expressed as mean ± SD.
(C) ATGL, HSL, and PLIN1 protein expression in WT and KO MEFs.
(D) Luciferase activity of Pnpla2 promoter reporter constructs transfected into 3T3-L1 adipocytes. Five days after adipogenic stimulation, 3T3-L1 cells were co-
transfected with the indicated promoter construct and an IRF4 expression plasmid (or control). Luciferase activity was measured 24 hr after transfection. Results
are are expressed as mean ± SD (n = 6). *p < 0.05 relative to EGFP.
(E) ChIP analysis in 3T3-L1 adipocytes overexpressing IRF4. The signal in IgG is set as 1. Results are expressed as mean ± SD.
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Adipose tissue is insulin sensitive, while spleen is not; the fact
that IRF4 expression is regulated in the former but not the latter
suggested to us that insulin might repress IRF4. This proved to
be the case, as cultured 3T3-L1 adipocytes treated with insulin
showed a dose- and time-dependent reduction in Irf4 mRNA
levels (Figure 1D and Figure S1C). To determine whether insulin
plays a similar role in vivo, we examined adipose tissue from
mice treated with streptozotocin, which causes b cell failure
and insulinopenia. In these animals, Irf4 mRNA expression in
WAT rose significantly, and decreased when insulin was
replaced (Figure 1E). Similarly, Irf4 mRNA levels were elevated
in mice lacking insulin receptors exclusively in adipose tissue
(so-called fat-specific insulin receptor knockout [FIRKO] mice
[Bluher et al., 2002]) (Figure 1F). Taken together, these findings
indicate that insulin is a potent repressor of IRF4 expression
and implicate the rise and fall of insulin during feeding and fasting
as a dominant determinant of IRF4 levels in fat. Consistent with
this notion, IRF4 expression is repressed in whole WAT of three
different rodent models of obesity, a hyperinsulinemic state (Fig-
ure S1D). As previously reported (Joken et al., 2007; Kershaw
et al., 2007), there was also a significant reduction of ATGL
mRNA in whole WAT of high-fat diet-induced obesity and
ob/ob mice compared to controls (Figure S1D). Fractionation
reveals that the obesity-induced reduction of Irf4 in whole WAT
predominantly reflects an effect in mature adipocytes; high-fat
feeding induces an increase in stromal-vascular IRF4 content,
consistent with adipose infiltration of macrophages (which also
express a significant amount of IRF4) in obesity (Figure S1E).
Many gene expression events affected by insulin aremediated
by the transcription factor forkhead box O1 (FoxO1), which isCephosphorylated and subsequently excluded from the nucleus
upon insulin stimulation (Biggs et al., 1999; Kops et al., 1999;
Nakae et al., 2000). To assess whether FoxO1 is an upstream
regulator of Irf4 transcription, we introduced wild-type (WT)
FoxO1, a constitutively active mutant FoxO1 (CA), a dominant-
negative FoxO1 mutant (DN), or EGFP control into mature 3T3-
L1 DCAR cells using adenovirus. Ectopic overexpression of
WT and CA FoxO1 caused a significant increase in basal Irf4
mRNA levels, while the DN mutant had the opposite effect (Fig-
ure 1G). Although insulin stimulation could still diminish Irf4
mRNA levels in WT cells, this effect was blocked in CA cells. In
silico analysis identified at least four predicted FoxO1 binding
sites in the proximal 8 kb of the murine Irf4 upstream flanking
sequence. We used serial deletion analysis of this region in
a luciferase reporter to identify the region between 1250 and
1320 base pairs upstream of the Irf4 transcriptional start site
as the insulin-responsive locus (Figure 1H), and chromatin immu-
noprecipitation (ChIP) assay in 3T3-L1 adipocytes confirmed
direct, insulin-sensitive FoxO1 binding to this region (Figure 1I).
IRF4 Is Required for Lipolysis In Vitro
Given the profound induction of IRF4 in fasted adipocytes, we
postulated a role for this transcription factor in lipolysis. To
address this, we generated immortalized lines of WT and Irf4/
(KO) mouse embryonic fibroblasts (MEFs) and then used retro-
viral expression of C/EBPa to convert these cells into adipocytes.
Oil redO staining and adipocytemarker gene expression demon-
strated that equal degrees of differentiation were achieved in
both cell lines (Figures S2A and S2B). As predicted, isoproter-
enol-stimulated lipolysis was diminished in adipocytes lacking
IRF4 (Figure 2A). The converse was also true; forced IRF4ll Metabolism 13, 249–259, March 2, 2011 ª2011 Elsevier Inc. 251
Figure 3. IRF4 Inhibits Lipogenesis In Vitro
(A) Insulin (100 nM) stimulation of 14C glucose incorporation into lipid was
determined in WT and KO MEFs, with and without the addition of exogenous
IRF4. *p < 0.05 (n = 6). Results are expressed as mean ± SD from three inde-
pendent experiments. *p < 0.05 relative toWT control under insulin stimulation,
#p < 0.05 relative to KO MEF under insulin stimulation.
(B) WT and KOMEFs were transduced with lentivirus expressing IRF4 or EGFP
5 days after differentiation induction. mRNA expression of lipogenesis genes
was measured with Q-PCR 7 days after infection. Results are expressed as
mean ± SD, n = 6.
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IRF4 Regulates Adipose Lipid Handlingoverexpression inmatureWTandKOadipocytes enhanced lipol-
ysis in the presence of isoproterenol (Figure 2A). IRF4 is a tran-
scription factor, so we hypothesized that expression of key
lipasesmight beaffectedby its absence. Indeed, lossof IRF4cor-
responded to a significant reduction in themRNA (Figure 2B) and
protein levels (Figure 2C) of Lipe (encoding HSL) and Pnpla2
(encoding ATGL). As in MEFs, forced IRF4 overexpression (Fig-
ure S2C) in mature 3T3-L1 adipocytes significantly enhanced
lipolysis in the presence of isoproterenol (Figure S2D) and
increased the expression of Lipe and Pnpla2mRNA (Figure S2E).
To investigate possible direct regulation of lipase gene expres-
sion by IRF4, we performed transactivation assays in 3T3-L1
cells. These studies demonstrated that IRF4 induced reporter
expression through predicted ISRE binding sites in the upstream
flanking region of Pnpla2 (Figure 2D), and ChIP assay confirmed
IRF4 binding to one of these sites (Figure 2E). While binding was
detected at several putative ISRE sites in the Lipe promoter, IRF4
was able to induce reporter expression even in the absence of
these motifs, suggesting the existence of an additional cryptic
binding site in the proximal promoter (Figures S2F and S2G).
These data indicate that IRF4 is required for lipolysis, at least
in part through direct induction of ATGL and HSL.
IRF4 Inhibits Lipogenesis
During feeding, adipose tissue stores excess calories as triglyc-
eride.While some lipids are importeddirectly from the circulation,
adipocytes also perform de novo lipogenesis. Because lipolysis
and lipogenesis are functionally opposed, we speculated that
IRF4might act to suppress lipogenesis and triglyceride synthesis.
This proved tobe the case, as insulinwasable to increase the rate
of lipid synthesis in KO adipocytes to a greater degree than inWT
cells (Figure 3A). Furthermore, forced expression of IRF4 sup-
pressed insulin-stimulated lipid synthesis and was able to fully
revert the lipogenic phenotype of cells lacking Irf4.
Consistent with the effect on lipogenesis, the expression of
genes related to lipid synthesis was regulated by IRF4 (Figure 3B).
All lipid synthesis genes testedwere repressed at least somewhat
by exogenous IRF4, whereas ablation of IRF4 led to significant
increases in select targets only, such as Scd1, Fasn, Srebf1, and252 Cell Metabolism 13, 249–259, March 2, 2011 ª2011 Elsevier Inc.Me1. Taken together, our data demonstrate coordinated regula-
tion of lipid synthesis and breakdown in cultured adipocytes.
Fat-Specific Deletion of IRF4 Results in Increased
Adiposity
We sought next to extend our in vitro findings to a more physio-
logically relevant system.Becausewewished to avoid confound-
ing effects in macrophages or other immune cell types, we
focused on a model that would allow observation of adipocyte-
specific actions of IRF4 in vivo. To that end, we generated
a BAC transgenic mouse in which Cre recombinase was inserted
into the starting ATG of Adipoq, which encodes adiponectin (see
the Experimental Procedures). Thesemice express Cre recombi-
nase in a highly adipocyte-specificmanner, with no expression in
stimulated or resident macrophages (Figures S3A–S3D). We
crossed these Adipoq-Cre mice to Irf4flox/+mice to allow genera-
tion of fat-specific IRF4 knockout mice (hereafter referred to as
FI4KO). FI4KO mice showed virtually complete absence of IRF4
mRNA and protein specifically in WAT and BAT, with intact
IRF4 expression in spleen and macrophages (Figures 4A and
4B). In addition to confirming the absence of IRF4, we also exam-
ined expression of the eight other IRF family members for
possible compensatory regulation. As we reported previously,
all IRF family members are detectable in WAT. We noted that
IRF6, IRF7, and IRF9 were upregulated in the absence of IRF4;
however, the significance of this upregulation is uncertain—
IRF6 and IRF9 in particular are expressed atmuch lower absolute
levels than IRF4 (Figure S4E). FI4KOmice were born in a Mende-
lian ratio, and there were no obvious morphological differences
fromcontrolmice (WT,Adipoq-Cre only, or Flox) in younganimals
(data not shown). On chow diet, total body weight was not
different from controls, although MRI revealed a small but signif-
icant excess of adipose mass in 18-week-old FI4KO animals
(Figures S4A and S4B). Histological analysis and cell size
measurement of WAT showed slightly larger adipocytes in
FI4KO mice than in littermate controls (Figures S4C and S4D).
When placed on a high-fat diet, the body weight of FI4KO mice
was significantly greater than that of littermates (Figures 4C and
4E), with the difference explained entirely by excess adiposity
and larger fat cells (Figures 4D, 4F, and 4G). Interscapular BAT
mass was also enlarged in high-fat fed FI4KO mice (Figures
4H). There was no obvious difference in hepatic lipid content
between Flox and FI4KO animals (data not shown). FI4KO mice
on high-fat diet showed impaired glucose and insulin tolerance
to a degree consistent with their increased body weight (Figures
S5A and S5B). We were unable to detect a difference in food
intake or locomotor activity; FI4KO mice showed somewhat
reducedoxygen consumption andCO2productionwhen normal-
ized by body weight (Figures S6A–S6C). This difference disap-
peared, however, when normalized on a per animal basis.
FI4KO Mice Exhibit Diminished Lipolysis
Basedon the invitro lipolysisdataand theexcessadiposity seen in
FI4KO mice, we speculated that IRF4 may be required for normal
lipolysis in vivo. To directly test this hypothesis, we measured
serum glycerol and nonesterified fatty acids (NEFA) under basal
and isoproterenol-stimulated conditions. Consistent with the
in vitro data, FI4KO mice displayed reduced isoproterenol-stimu-
lated lipolysis (Figure 5A).Wealso tested this after high-fat feeding
Figure 4. Characterization of Fat-Specific
IRF4 KO Mice
(A) Irf4 mRNA expression in WAT, BAT, spleen,
and peritoneal macrophages of male Irf4f/f (Flox)
and FI4KO (KO) mice (n = 3). Data are normalized
to 36B4. *p < 0.05 relative to Floxmice. Results are
expressed as mean ± SD.
(B) IRF4 protein expression in WAT, BAT, spleen,
and peritoneal macrophages of male Adipoq-Cre
and FI4KO (KO) mice.
(C) Body weights of male WT, Adipoq-Cre, Flox,
and FI4KO (KO) mice on high-fat diet (n = 8–10).
Results are expressed as mean ± SD.
(D) Body composition analysis in 14-week-old
malemice (n=8–10) byMRI.Results are expressed
as mean ± SD, *p < 0.05 relative to Flox mice.
(E) Morphology of FI4KO (KO) mice (16 month old)
and fat pads after high-fat feeding.
(F) Hematoxylin and eosin staining of paraffin-
embedded epididymal WAT sections from 16-
month-old mice. Scale bars represent 50 mm.
(G) Representative cell size distribution of adipo-
cytes in epididymal WAT from Flox and FI4KO
(KO) mice.
(H) Gross appearance and hematoxylin and eosin
staining of paraffin-embedded BAT sections from
16-month-old mice. Scale bars represent 50 mm.
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determine whether this effect was truly cell autonomous, we iso-
lated primary adipocytes from Irf4flox/flox and FI4KO mice and
compared lipolysis in these cells in the ex vivo setting. Indeed,
primary adipocytes from FI4KO mice display reduced lipolysis in
both the basal and catecholamine-stimulated state (Figures 5B
and 5C). Q-PCR analysis demonstrated reduced fasting Pnpla2
and Lipe expression (Figure 5D). Conversely, and consistent
with the in vitro data, genes of lipid uptake (e.g., Slc27a1 and
Cd36) and lipid synthesis (e.g., Dgat1, Dgat2, and Fasn) show
enhanced expression in the fed state in FI4KO mice (Figure 5D).
These data suggest that reduced lipolysis and increased lipogen-
esis in fat may be reflected in the higher adiposity of FI4KO mice.
Finally, we sought to test the ability of FI4KO mice to respond
to two situations that require lipolysis. First, we subjected FI4KO
and control mice to a prolonged fast of 48 hr. FI4KO mice lost
less body fat than control mice during this provocation (Fig-
ure 6A), consistent with their lower serum nonesterified fatty
acids and b-hydroxybutyrate (Figure 6B).
We next examined cold-induced thermogenesis of Flox
and FI4KO mice. At an ambient temperature of 22C, FloxCell Metabolism 13, 249–2andFI4KOmicehadsimilarbody tempera-
tures. However, at 4C, FI4KOmice expe-
rienced amuchmore rapid decline in body
temperature than seen in Flox mice (Fig-
ure 7A). Furthermore, cold exposure was
much less able to induce Ucp1 and
Pgc1a in BAT of FI4KO mice (Figure 7B).
DISCUSSION
IRF4 is a well-known participant in
a variety of immune activities, includingregulatory T cell function and the development of inflammatory
T(H)-17 cells, as well as plasma cell differentiation (Brustle
et al., 2007; Klein et al., 2006; Mittrucker et al., 1997; Zheng
et al., 2009).Micemade globally deficient in IRF4 develop lymph-
adenopathy and lack functional germinal B cell centers and
normal plasma cells (Mittrucker et al., 1997). Previously, we iden-
tified WAT and BAT as major sites of IRF4 expression, though its
function in these tissues was not apparent. The discovery that
IRF4 expression is extraordinarily sensitive to fasting and feeding
suggested a role in nutrient partitioning.
Metabolic control of lipolysis has been most intensively
studied at the level of nutritionally sensitive signal transduction
cascades, rather than transcriptional regulation. Lipolysis is
induced acutely in fasting by b-adrenergic signaling leading to
cAMP accumulation and subsequent PKA-mediated phosphor-
ylation of HSL and the lipid droplet protein perilipin (Carmen and
Victor, 2006; Jocken and Blaak, 2008). In the fed state, insulin
inhibits lipolysis via mechanisms that are somewhat less clear,
although a role has been postulated for insulin-mediated activa-
tion of phosphodiesterase 3B, which hydrolyzes cAMP (Kita-
mura et al., 1999;Wijkander et al., 1998). Our work demonstrates59, March 2, 2011 ª2011 Elsevier Inc. 253
Figure 5. IRF4 Is Required for Lipolysis
In Vivo and Ex Vivo
(A) Lipolysis in Flox and FI4KO (KO) mice on chow
diet. Glycerol and NEFA in plasma were measured
in the absence and presence of 10 mM of isopro-
terenol. Results are expressed as mean ± SD,
*p < 0.05, versus Flox mice (n = 8).
(B and C) Rate of lipolysis in isolated adipocytes.
Adipocytes were isolated from epididymal fat of
male Flox and FI4KO (KO) mice. Glycerol and
NEFA release were measured in the absence and
presence of 10 mM of isoproterenol. Results are
expressed as mean ± SD, *p < 0.05 relative to
Flox mice (n = 3).
(D) Q-PCR analysis of the indicated mRNAs in
the adipocyte fraction of epididymal WAT from
12-week-old Flox or FI4KO (KO) mice on chow
diet (n = 5) under fed and 24 hr fasting conditions.
All samples are normalized to 36B4. Results
expressed as mean ± SD, *p < 0.05, versus Flox
mice.
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IRF4 Regulates Adipose Lipid Handlingan additional mechanism by which insulin inhibits lipolysis, albeit
on a longer time scale, through the cytosolic sequestration of
FoxO1 and subsequent reduction of IRF4 expression. IRF4
promotes lipolysis, at least in part, by inducing the expression
of the lipases ATGL and HSL. These data are consistent with
prior studies showing that insulin regulates ATGL expression in
3T3-L1 cells and mice (Kershaw et al., 2006). Interestingly,
FoxO1 has been shown to directly activate the Pnpla2 promoter
in 3T3-L1 adipocytes (Chakrabarti and Kandror, 2009). Our254 Cell Metabolism 13, 249–259, March 2, 2011 ª2011 Elsevier Inc.discovery that FoxO1 directly induces
IRF4 implies the existence of an insulin-
repressible feed-forward loop involving
these two factors. Several other factors
have recently been discovered to acutely
regulate lipolysis, such as CGI-58 (Lass
et al., 2006), AdPLA (Jaworski et al.,
2009), and G0S2 (Yang et al., 2010);
however, we have not been able to
demonstrate significant effects of IRF4
on the expression of any of these media-
tors (data not shown). Similarly, we
have looked at upstream components
of the lipolysis machinery, including
levels of cAMP and phospho-HSL, but
have so far not found significant or
consistent IRF4-dependent effects (data
not shown).
Lipogenesis is regulated by the nutri-
tional environment, in particular by
feeding and fasting. In adipocytes, lipo-
genesis is activated by a high carbohy-
drate supply and by the actions of insulin.
These actions are mediated by transcrip-
tion factors such as SREBP1c, ChREBP,
and LXR. We have shown that IRF4
inhibits insulin-induced lipogenesis in
cultured adipocytes and that IRF4 is
associated with reduced expression ofgenes related to lipid synthesis. It is not yet clear, however, which
genes are most relevant to the repression of lipogenesis by IRF4,
or whether the effect is direct or indirect. It is worth noting that
the effect of IRF4 on lipogenic gene expression was only seen
in the fed state, which is when insulin levels are highest. This
may seem counterintuitive, given our demonstration that insulin
represses IRF4 expression. However, IRF4 expression is still
detectable after feeding, and this appears to be sufficient to
repress lipogenic genes.
Figure 6. FI4KO Mice Have an Aberrant
Response to Prolonged Fasting
(A) Response of FI4KO mice to prolonged fasting.
Results are expressed as mean ± SD, *p < 0.05
relative to Flox mice (n = 9).
(B) NEFA levels after 48 hr of fasting (n = 9mice per
group; *p < 0.05).
(C) b-hydroxybutyrate levels after 48 hr of fasting
(n = 9 mice per group; *p < 0.05). Data are
expressed as mean ± SD.
Figure 7. FI4KO Mice Are Cold Intolerant
(A) Rectal temperature of Flox and FI4KO (KO) mice during cold exposure
(4C). Results are expressed as mean ± SD, *p < 0.05 relative to Flox mice
(n = 7 mice per group).
(B) Expression ofDio2,Cidea,Ucp1, and Pgc1a in BAT after cold exposure for
6 hr (n = 7 mice per group; *p < 0.05). Data are expressed as mean ± SD.
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support an effect in BAT, as well. FI4KO mice (which express
Cre in BAT as well as WAT) showed increased BAT mass asso-
ciated with larger lipid droplets. Furthermore, FI4KO mice were
cold intolerant. This phenomenon may be due to reduced fatty
acid availability from WAT stores preventing optimal BAT func-
tion by diminishing substrate. However, we also see reduced
PGC-1a and UCP-1 expression in the BAT of FI4KO mice, sug-
gesting that additional mechanisms may be at play, such as
abnormal adrenergic signaling.
Interestingly, Irf4 mRNA levels are reduced in obesity. This
may seem paradoxical, given that obesity is associated with
insulin resistance andmice lacking insulin receptors in fat display
elevated Irf4 expression. However, the insulin resistance associ-
ated with obesity is defined by its effects on the metabolic
actions of insulin. Many genes respond normally to insulin even
in the context of ‘‘insulin resistance’’ (Samad et al., 2000; Sartipy
and Loskutoff, 2003). It also remains possible that other factors
dominate the control of Irf4 gene expression in the context of
obesity.
While IRF4 is believed to act primarily as a transcription factor,
there are some data from macrophages suggesting that it may
appear in small amounts in the cytosol, where it can bind and
inhibit TLR4 (Honma et al., 2005; Negishi et al., 2005). TLR4
signaling, however, is known to activate lipolysis (Zu et al.,
2009), making this an unlikely mechanism for the prolipolytic
actions of IRF4. Definitive proof of this will require experiments
using DNA binding mutant alleles of IRF4.
Because IRF4 is expressed in macrophages and lympho-
cytes, both of which can affect metabolic pathways in adipose
tissue (Honma et al., 2005; Marecki et al., 1999; Tamura et al.,
2008), we sought to perform studies in vivo using a model that
would reduce or eliminate confounding effects from immune
cell types. Cre-lox recombination offers such an opportunity;
however, the traditional adipose-selective Cre-driver mouse
uses the Fabp4 (also called aP2) promoter (Abel et al., 2001;
Barlow et al., 1997). This is problematic because Fabp4 is
expressed in macrophages as well as in fat (Fu et al., 2002;
Makowski et al., 2001). Additionally, other problems haveCell Metabolism 13, 249–2been associated with the Fabp4-Cre
mouse, including poor recombination
efficiency (Halberg et al., 2009). To
circumvent these issues, we generated
an adipose-specific Cre BAC transgenic
mouse line, in which Cre recombinase
was inserted into the starting ATG of
the adiponectin (Adipoq) locus. Thesemice express Cre effectively in WAT and BAT but not in
macrophages, including adipose-tissue resident macrophages,
alveolar macrophages, or thioglycollate-stimulated peritoneal
macrophages. These mice, which we call Adipoq-Cre, thus
provide a new and highly effective reagent for adipose-specific
gene loxP-mediated gene recombination. We note that another
group has recently generated their own version of these mice,
using a 5.4 kb promoter fragment of the Adipoq gene rather
than an intact BAC (Wang et al., 2010).
FI4KO mice display increased adiposity and are resistant to
lipolysis induced by catecholamines, fasting, or cold exposure.
Depletion of IRF4 in WAT also impaired the normal regulation
of lipid synthesis genes (Plin2, Fasn, Slc27a1, and CD36) during
the fasting and feeding cycle. Taken together with our in vitro
observations, these data indicate that IRF4 is a critical transcrip-
tional regulator of lipid handling in fat. There is significant interest
in developing anti-inflammatory drugs as therapy for metabolic
diseases like type 2 diabetes. Some ‘‘inflammatory’’ proteins,
however, like IRF4, may play key roles in metabolic function
independent of their effect on immunity. Such nuances will
need to be fully explored before the potential of this therapeutic
avenue can be fully realized.59, March 2, 2011 ª2011 Elsevier Inc. 255
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Materials
Antibodies for western blotting were purchased from Santa Cruz Biotech-
nology (IRF4, sc-6059; Actin, sc-1615), Cell Signaling Technology (ATGL,
2138; HSL, 4107) and Millipore (Tubulin, MAB3408). The coding region of
mouse IRF4 was isolated from 3T3-L1 adipocyte mRNA by RT-PCR with
TaKaRa EX Taq polymerase (Takara Bio) and subcloned into pCDH-puro
lentiviral vector (System Biosciences) for expression in mammalian cells.
The coding sequence of mouse C/EBPawas subcloned into pREV-TRE-hygro
retroviral vector as described (Zuo et al., 2006). Adenoviral vectors for EGFP,
FoxO1, ADA (constitutive active mutant), and D256 (dominant-negative
mutant) were made in pAxCAwt (Takara Bio) as described (Nakae et al.,
2001). All FoxO1 constructs were the generous gift of D. Acilli.
Cell Culture
3T3-L1 cells (American Type Culture Collection) or 3T3-L1DCAR cells (Orlicky
et al., 2001) were cultured in Dulbecco’s modified Eagle’s medium (DMEM;
Invitrogen) with 10% bovine calf serum (BCS; Hyclone) in 5% CO2. Two
days after confluence, cells were exposed to DMEM/10% fetal bovine serum
(FBS; Invitrogen) with 1 mM dexamethasone (Sigma), 5 mg/ml insulin (Sigma),
and 0.5 mM isobutylmethylxanthine (Sigma). After 2 days, cells were main-
tained in medium containing FBS only. For insulin regulation experiments, fully
differentiated 3T3-L1 adipocytes were incubated in serum-free DMEM con-
taining 1% fatty acid-free bovine serum albumin (BSA) (Sigma) with and
without bovine insulin at the doses and times indicated.
Generation and Differentiation of Immortalized Mouse Embryonic
Fibroblasts
Irf4+/ mice were generated as previously described (Mittrucker et al., 1997).
Male and female Irf4+/ mice were mated, and embryos were harvested at
e12.5. Primary MEFs were generated and plated as monolayer cultures in
DMEM with 10% FBS as described previously (Rosen et al., 2002). Primary
MEFs were immortalized by plating of 3 3 105 cells per 60 mm dish every
3 days as described (Todaro andGreen, 1963). The C/EBPa-pMSCV construct
was transfected into Phoenix packaging cells with the CellPhect transfection
kit (Amersham Biosciences). Immortalized MEFs were transduced with
viral supernatants and selected in hygromycin. Two days after confluence,
cells were exposed to DMEM/10% FBS with dexamethasone (1 mM), insulin
(5 mg/ml), isobutylmethylxanthine (0.5 mM), and rosiglitazone (1 mM). After
2 days, cells were maintained in medium containing FBS only.
Animals
Fasting and feeding studies were performed with FVB mice obtained from
Charles River Laboratories and fed a standard diet (8664, Harlan Teklad).
Mice were maintained under a 14 hr light/10 hr dark cycle at constant temper-
ature (22C) with free access to food and water. For determination of the effect
of nutritional status, 10-week-oldmale FVBmicewere fed ad libitum, fasted for
24 hr, or refed for 24 hr after the 24 hr fast (n = 7–8). For determination of
the effect of insulin deficiency and replacement on IRF4 mRNA expression,
10-week-old male C57BL/6J mice were treated with streptozotocin (STZ)
with or without insulin replacement as described (Kershaw et al., 2006). All
animal studies were approved by the Institutional Animal Care and Use
Committee of Beth Israel Deaconess Medical Center. WAT of FIRKO mice
was generously provided by C. Ronald Kahn. The 16-week-old ob/ob and
db/db mice were purchased from the Jackson Laboratory. For DIO mice,
C57BL/6Jmicewere fed a high-fat diet (D12331; ResearchDiets) for 12weeks.
Body weight and food intake were measured weekly. Mice were subjected to
magnetic resonance imaging (MRI) (Echo Medical Systems) to examine body
composition.
Generation of Adipoq-Cre Transgenic Mice
A C57Bl/6 mouse bacterial artificial chromosome (90G21) containing the
Adipoq gene was transformed into the recombinogenic EL250 bacteria cells,
and homologous recombination was performed as described elsewhere
(Lee et al., 2001). The Cre-FRT-Kan-FRT cassette was transformed into the
Adipoq BAC host EL250 cells and recombined to insert the Cre ATG into the
Adipoq ATG, with a resulting deletion of 222 bp of the Adipoq gene. Adipoq-256 Cell Metabolism 13, 249–259, March 2, 2011 ª2011 Elsevier Inc.Cre-FRT-Kan-FRT BAC host EL250 clones were identified by PCR screening.
The FRT-Kan-FRT cassette was removed, and an Adipoq-Cre BAC host
EL250 clone without mutation in the Cre coding sequence was obtained.
The loxP site present in the vector sequence of the Adipoq-Cre BAC was
removed. The transgenic construct was microinjected into pronuclei of fertil-
ized one-cell stage embryos of FVB mice (Jackson Laboratories) via standard
methods. Twelve founders were obtained. The Adipoq-Cre founder was back-
crossed more than eight times onto C57BL/6J prior to use in these experi-
ments. Adipoq-Cre mice have been deposited at the Jackson Laboratory
Repository with JAX stock number 010803.
Generation of FI4KO Mice
Irf4flox/flox mice were generated as described previously (Klein et al., 2006).
Adipoq-Cre mice were mated with Irf4flox/flox mice, and cohorts were estab-
lished by mating F1 Irf4flox/+; Cre+ mice to littermate Irf4flox/+; Cre mice.
Mice were maintained under a 14 hr light/10 hr dark cycle at constant temper-
ature (22C) with free access to food and water and were fed either a standard
chow diet (8664, Harlan Teklad) or a high-fat diet (D12331; Research Diets
Inc.).
Isolation of Primary Cells
Adipocytes were isolated from epididymal fat depots in Krebs-Ringer HEPES
(KRH) buffer by collagenase digestion as described (Joost and Schurmann,
2001). Peritoneal macrophages from Adipoq-Cre, Irf4flox/flox mice and FI4KO
mice were isolated by peritoneal lavage 4 days after injection of 3% thioglycol-
late (2.5 ml intraperitoneal; Difco; BD Diagnostics).
Measurement of Adipocyte Size
Epididymal WAT was isolated and fixed in osmium tetroxide solution (Sigma-
Aldrich). The destribution of adipocyte size in WAT was analyzed by a Coulter
counter (Multisizer II, Coulter Electronics) as described previously (DiGirolamo
and Fine, 2001).
Serum Analysis
After collection of serum from tail vein, b-hydroxybutyrate (StanBio) and
nonesterified fatty acids (NEFAs) (Wako Chemicals) were measured in dupli-
cate with colorimetric assays.
Cold-Induced Thermogenesis
Rectal temperature was measured with a rectal probe (Yellow Spring Instru-
ments) in Flox and FI4KO (KO) mice under the cold exposure.
Indirect Calorimetry
Metabolic rate of mice was measured by indirect calorimetry in open-circuit
oxymax chambers that are a component of the Comprehensive Lab Animal
Monitoring System (CLAMS; Columbus Instruments, Columbus, OH). Mice
were housed individually and maintained at 22C under a 12 hr light/12 hr
dark cycle. Food and water were available ad libitum.
Human Subjects
Healthy male adults ages 18–60 with a body mass index of 19–39 kg/m2
without significant medical illness were recruited by advertisement for partic-
ipation. Individuals with diabetes, heart disease, liver disease, renal insuffi-
ciency, thyroid disease, gout, or a history of kidney stones were excluded.
Individuals with a history of alcohol abuse or marijuana use were also
excluded. Subjects reported stable weight (± 3kg) for 6 months prior to partic-
ipation. All subjects underwent a screening visit that included a medical
history, physical exam, and baseline laboratory tests. Patients gave written
informed consent to all clinical investigations, which were performed in accor-
dance with the principles embodied in the Declaration of Helsinki. The proto-
cols were conducted in accordance with the ethical standards of the
Committee on Clinical Investigation and were approved by the Beth Israel
Deaconess Medical Center Institutional Review Board. The studies were con-
ducted from June 2007 to April 2010 at the Beth Israel Deaconess Medical
Center, General Clinical Research Center (Boston, MA), http://clinicaltrials.
gov/ identifier NCT00476125. After a screening visit, five healthy, lean male
subjects reported to the GCRC at 8 a.m. for a standard 500 calorie breakfast.
One hour after the meal, subjects underwent a subcutaneous fat biopsy and
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vidual who terminated the fast after 50 hr due to fatigue. Body weight and
body composition were measured daily. A second subcutaneous fat biopsy
was done at the end of the fasting period, before the subjectwas fed a standard
meal. Clinical data are presented in Table S1.
Analysis of Gene Expression by Q-PCR
Total RNA was extracted from cells or tissues with TRIzol reagent (Invitrogen)
according to the manufacturer’s instructions. First-strand complementary
DNA (cDNA) synthesis was performed with RETROscript (Ambion). Total
RNA was converted into first-strand cDNA with oligo(dT) primers as described
by the manufacturer. PCR was performed with cDNA synthesized from 1.5 mg
total RNA in an Mx3000P Q-PCR system (Stratagene) with specific primers
and SYBR Green PCR Master Mix (Stratagene). The relative abundance of
mRNAs was standardized with 36B4 mRNA as the invariant control. Primers
used are listed in Table S2.
Luciferase Reporter Assay
The indicated regions of the murine Irf4, Pnpla2 (ATGL), and Lipe (HSL)
promoters were PCR amplified and ligated into pGL3-Basic (Promega). Five
days after adipogenic stimulation, 3T3-L1 adipocytes were detached with
trypsin and transfected using the Amaxa nucleofection system (Amaxa Biosys-
tems). Transfections were performed with 2 mg reporter construct along with
100 ng IRF4-pCDH expression vector or EGFP-pCDH, with 100 ng galactosi-
dase expression vector as a transfection control. Luciferase activity was
measured 24 hr after transfection with the Galacto-Star luciferase reporter
assay (Roche) according to the manufacturer’s instructions.
Chromatin Immunoprecipitation
3T3-L1 cells were treated with 1% formaldehyde for 10 min at room tempera-
ture to crosslink DNA-protein complexes. Genomic DNA was sheared with
a Sonic Dismembrator Model 100 (Fisher Scientific) to obtain fragments
ranging from 200 bp to 1 kb. ChIP was performed with a kit from Upstate,
with 3 mg primary antibody, goat IgG, or rabbit IgG. The following primary anti-
bodies were used: goat anti-IRF4 (sc-6059), or rabbit anti-FoxO1 (sc-11350)
(Santa Cruz Biotechnology). Crosslinking was reversed and purified DNA
was subjected to Q-PCR with SYBR green fluorescent dye (Stratagene).
Primers used are listed in Table S2.
Protein Extraction and Western Blot Analysis
Tissue and cell lysates were prepared with RIPA buffer (Boston BioProducts)
supplemented with complete protease inhibitor cocktail (Roche). For western
blot analyses, 50mgproteinwassubjected toSDS-PAGEunder reducingcondi-
tions, transferred, and blotted with the anti-IRF4 antibody described above.
Lipolysis Assay
For in vitro studies, adipocytes were washed twice with DMEM and then incu-
bated for 6 hr in serum-free DMEM containing 1% fatty acid-free BSA in the
presence or absence of 10 mM isoproterenol. Conditioned medium was then
analyzed for glycerol with the Free Glycerol Determination Kit (Sigma). Adipo-
cytes were then rinsed with PBS and harvested in RIPA buffer. The protein
content of cell lysates was determined with the DC Protein Assay kit (BioRad).
For ex vivo studies, adipocytes were isolated from epididymal fat pads by
collagenase digestion. Cells were resuspended in Krebs-Ringer HEPES
(KRH) buffer at 2 3 105 cells/ml. Cells were incubated in the presence or
absence of 1 mM isoproterenol for 0–2 hr at 37C with gentle shaking. Glycerol
and NEFA content of conditioned medium was determined as above. For
in vivo studies, mice were fasted for 4 hr and injected with isoproterenol
(10 mg/kg body weight). Blood was collected from the tail vein before and
15 min after injection, and glycerol and NEFA content of serum was measured
as above.
Lipogenesis Assay
Lipogenesis assays were performed as previously described (Wiese et al.,
1995). In brief, after serum starvation, cells were incubated in the presence
or absence of 10 nM insulin for 15 min and incubated with 5 mM [14C]-glucose
for 1 hr at 37C. Cells were then washed three times with ice-cold PBS.
Radiolabeled glucose incorporation into lipid was assessed by scraping cellsCeinto 1 ml PBS and shaking vigorously with 5 ml Betaflour Liquid Scintillation
Fluid (National Diagnostics). After samples settled overnight, radioactivity par-
titioning into the organic phase was determined by scintillation counting. The
protein content of cell lysates was determined with the DC Protein Assay kit.
Statistical Analysis
Unpaired two-tailed Student’s t tests and one-way ANOVAwere used. p < 0.05
was considered statistically significant.
SUPPLEMENTAL INFORMATION
Supplemental Information includes seven figures and two tables and can be
found with this article online at doi:10.1016/j.cmet.2011.02.005.
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